151 related articles for article (PubMed ID: 38019076)
1. Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation.
Guyonnet E; Kim SJ; Xia YY; Giannakeas V; Lubinski J; Randall Armel S; Eisen A; Bordeleau L; Eng C; Olopade OI; Tung N; Foulkes WD; Couch FJ; Aeilts AM; Narod SA; Kotsopoulos J
Cancer Res Commun; 2023 Nov; 3(11):2420-2429. PubMed ID: 38019076
[TBL] [Abstract][Full Text] [Related]
2. Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Lammert J; Lubinski J; Gronwald J; Huzarski T; Armel S; Eisen A; Meschino WS; Lynch HT; Snyder C; Eng C; Olopade OI; Ginsburg O; Foulkes WD; Elser C; Cohen SA; Kiechle M; Narod SA; Kotsopoulos J
Breast Cancer Res Treat; 2018 Jun; 169(3):561-571. PubMed ID: 29404807
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Gronwald J; Cybulski C; Demsky R; Neuhausen SL; Kim-Sing C; Tung N; Friedman S; Senter L; Weitzel J; Karlan B; Moller P; Sun P; Narod SA;
Int J Cancer; 2015 Sep; 137(5):1136-46. PubMed ID: 25482078
[TBL] [Abstract][Full Text] [Related]
4. Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Kotsopoulos J; Gronwald J; McCuaig JM; Karlan BY; Eisen A; Tung N; Bordeleau L; Senter L; Eng C; Couch F; Fruscio R; Weitzel JN; Olopade O; Singer CF; Pal T; Foulkes WD; Neuhausen SL; Sun P; Lubinski J; Narod SA;
Gynecol Oncol; 2020 Dec; 159(3):820-826. PubMed ID: 33010967
[TBL] [Abstract][Full Text] [Related]
5. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
McLaughlin JR; Risch HA; Lubinski J; Moller P; Ghadirian P; Lynch H; Karlan B; Fishman D; Rosen B; Neuhausen SL; Offit K; Kauff N; Domchek S; Tung N; Friedman E; Foulkes W; Sun P; Narod SA;
Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
Schrijver LH; Antoniou AC; Olsson H; Mooij TM; Roos-Blom MJ; Azarang L; Adlard J; Ahmed M; Barrowdale D; Davidson R; Donaldson A; Eeles R; Evans DG; Frost D; Henderson A; Izatt L; Ong KR; Bonadona V; Coupier I; Faivre L; Fricker JP; Gesta P; van Engelen K; Jager A; Menko FH; Mourits MJE; Singer CF; Tan YY; Foretova L; Navratilova M; Schmutzler RK; Ellberg C; Gerdes AM; Caldes T; Simard J; Olah E; Jakubowska A; Rantala J; Osorio A; Hopper JL; Phillips KA; Milne RL; Beth Terry M; Noguès C; Engel C; Kast K; Goldgar DE; van Leeuwen FE; Easton DF; Andrieu N; Rookus MA;
Am J Obstet Gynecol; 2021 Jul; 225(1):51.e1-51.e17. PubMed ID: 33493488
[TBL] [Abstract][Full Text] [Related]
7. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H
JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Xia YY; Gronwald J; Karlan B; Lubinski J; McCuaig JM; Brooks J; Moller P; Eisen A; Sun S; Senter L; Bordeleau L; Neuhausen SL; Singer CF; Tung N; Foulkes WD; Sun P; Narod SA; Kotsopoulos J;
Gynecol Oncol; 2022 Mar; 164(3):514-521. PubMed ID: 35063280
[TBL] [Abstract][Full Text] [Related]
9. The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers.
Laitman Y; Kuchenbaecker KB; Rantala J; Hogervorst F; Peock S; Godwin AK; Arason A; Kirchhoff T; Offit K; Isaacs C; Schmutzler RK; Wappenschmidt B; Nevanlinna H; Chen X; Chenevix-Trench G; Healey S; Couch F; Peterlongo P; Radice P; Nathanson KL; Caligo MA; Neuhausen SL; Ganz P; Sinilnikova OM; McGuffog L; Easton DF; Antoniou AC; Wolf I; Friedman E
Breast Cancer Res Treat; 2012 Apr; 132(3):1119-26. PubMed ID: 22212556
[TBL] [Abstract][Full Text] [Related]
10. Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gronwald J; Glass K; Rosen B; Karlan B; Tung N; Neuhausen SL; Moller P; Ainsworth P; Sun P; Narod SA; Lubinski J; Kotsopoulos J;
Fertil Steril; 2016 Mar; 105(3):781-785. PubMed ID: 26698676
[TBL] [Abstract][Full Text] [Related]
11. Germline BRCA variants, lifestyle and ovarian cancer survival.
Gersekowski K; Delahunty R; Alsop K; Goode EL; Cunningham JM; Winham SJ; Pharoah P; Song H; Jordan S; Fereday S; DeFazio A; Friedlander M; Obermair A; ; ; Webb PM
Gynecol Oncol; 2022 Jun; 165(3):437-445. PubMed ID: 35400525
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2.
Ingham SL; Warwick J; Buchan I; Sahin S; O'Hara C; Moran A; Howell A; Evans DG
J Med Genet; 2013 Jun; 50(6):368-72. PubMed ID: 23539753
[TBL] [Abstract][Full Text] [Related]
13. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Villarreal-Garza C; Alvarez-Gómez RM; Pérez-Plasencia C; Herrera LA; Herzog J; Castillo D; Mohar A; Castro C; Gallardo LN; Gallardo D; Santibáñez M; Blazer KR; Weitzel JN
Cancer; 2015 Feb; 121(3):372-8. PubMed ID: 25236687
[TBL] [Abstract][Full Text] [Related]
14. Assessment of ovarian reserve and reproductive outcomes in
Ponce J; Fernandez-Gonzalez S; Calvo I; Climent M; Peñafiel J; Feliubadaló L; Teulé A; Lázaro C; Brunet JM; Candás-Estébanez B; Durán Retamal M
Int J Gynecol Cancer; 2020 Jan; 30(1):83-88. PubMed ID: 31780568
[TBL] [Abstract][Full Text] [Related]
15. Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Olopado OI; Ghadirian P; Lubinski J; Lynch HT; Isaacs C; Weber B; Kim-Sing C; Ainsworth P; Foulkes WD; Eisen A; Sun P; Narod SA
Breast Cancer Res; 2005; 7(5):R833-43. PubMed ID: 16168130
[TBL] [Abstract][Full Text] [Related]
16. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
Zhong Q; Peng HL; Zhao X; Zhang L; Hwang WT
Clin Cancer Res; 2015 Jan; 21(1):211-20. PubMed ID: 25348513
[TBL] [Abstract][Full Text] [Related]
17. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
18. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
Oh M; Alkhushaym N; Fallatah S; Althagafi A; Aljadeed R; Alsowaida Y; Jeter J; Martin JR; Babiker HM; McBride A; Abraham I
Prostate; 2019 Jun; 79(8):880-895. PubMed ID: 30900310
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
[TBL] [Abstract][Full Text] [Related]
20. The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Metcalfe KA; Gronwald J; Tung NM; McCuaig JM; Eisen A; Elser C; Foulkes WD; Neuhausen SL; Senter L; Moller P; Bordeleau L; Fruscio R; Velsher L; Zakalik D; Olopade OI; Eng C; Pal T; Cullinane CA; Couch FJ; Kotsopoulos J; Sun P; Lubinski J; Narod SA
Cancer; 2023 Mar; 129(6):901-907. PubMed ID: 36571512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
